Business

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5129273 for the full story.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5122556 for the full story.

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5118390 for the full story.

Medtronic Inc. (MDT) recently launched a new TSRH 3Dx Spinal System, which is a hook, rod and screw system used in complex spinal procedures. The system offers two screws designed to address multiple pathologies. The Multi Planar Adjusting (MPA) Screw gives surgeons the flexibility of a variable angle posted screw for targeted, controlled correction maneuvers. [...]

(MDT) Medtronic Launches New Product for Complex Pinal Procedures

When we posted on Nov. 12 about the flurry of margin calls at Boston Scientific Corp. (BSX), there was no way to know that the pace of involuntary stock sales would continue. As a historical recap:  Michelle noted in her post last week that company co-founders Peter Nicholas and John Abele sold off over 30 million [...]

Medtronic Inc. (MDT) recently launched a new TSRH 3Dx Spinal System, which is a hook, rod and screw system used in complex spinal procedures. The system offers two screws designed to address multiple pathologies. The Multi Planar Adjusting (MPA) Screw gives surgeons the flexibility of a variable angle posted screw for targeted, controlled correction maneuvers. The OSTEOGRIP Screw enhances bone fixation by incorporating a dual-lead thread pattern that reduces toggle at the bone-screw interface.

The new pedicle screw system has a unique technology that addresses multiple spinal pathologies, from degenerative disc disease to spinal deformity. The product offers an alternative to patients for spinal stabilization with fusion. It works for patients suffering from degenerative spinal conditions, deformity, or injury of the thoracic, lumbar, and sacral spine. The TSRH Spinal System also provides Chromaloy rods and a minimally invasive capability.

We think that the new product will be widely accepted by orthopedic surgeons as a result of its unique features. This will expand Medtronic’s revenues in the Spinal and Biologics segment.
Medtronic is one of the world’s leading medical technology companies, specializing in implantable and interventional therapy devices and products. The company’s main competitors include St. Jude Medical (STJ) and Boston Scientific Corporation (BSX).

Medtronic’s management has a typical “ONE Medtronic" approach that encompasses the following goals: drive sustainable long-term growth of 9%−11% through innovation, focus on operating margins − increase by 300 to 400 basis points, EPS growth of 11%−14% and return a minimum of 40%−50% of free cash flow to shareholders annually, and align the organization for consistent execution. Medtronic’s fiscal first quarter results indicate that the company is well on track to achieve these goals.

Read the full analyst report on "MDT"
Read the full analyst report on "STJ"
Read the full analyst report on "BSX"
Zacks Investment Research

Medtronic, Inc. (MDT) recently launched MASTERGRAFT Strip – a new, highly flexible ceramic scaffold used in combination with a patient’s own bone for fusing multiple levels of the posterolateral spine, in the U.S. The strip is used by surgeons for a variety of bone grafting procedures. MASTERGRAFT Strip is primarily used when the spine loses stability [...]

(MDT) Medtronic, Inc Launches New Bone Grafter

Medtronic Inc. (MDT) recently reported the first enrollment for its Attain Success trial. The trial evaluates implant success, complication rates and procedure times for the company’s Attain Family of left-heart leads and delivery systems portfolio which are already available in the market. The Attain Success trial enrollment will have roughly 2,000 patients at 150 medical centers [...]

(MDT) Medtronic Reports Enrollment in its Attain Success Trial

Schaeffer's analyst Morgan Searcy takes a look at news on the Street before the market open.

Schaeffer's Laura Houser takes a look at activity on the Street after the market close

Andrea Kramer takes a look at news on the Street ahead of the market open

Joseph Hargett takes a look back at news that drove the major market indices today.

Elizabeth Harrow takes a look at news on the Street before the market opens.